A
A. Guillen
Researcher at King Juan Carlos University
Publications - 14
Citations - 599
A. Guillen is an academic researcher from King Juan Carlos University. The author has contributed to research in topics: Embryo transfer & Intracytoplasmic sperm injection. The author has an hindex of 6, co-authored 13 publications receiving 468 citations.
Papers
More filters
Journal ArticleDOI
In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study
Carmen Rubio,José Bellver,Lorena Rodrigo,Gema Castillón,A. Guillen,C. Vidal,Juan Giles,Marcos Ferrando,Sergio Cabanillas,José Remohí,Antonio Pellicer,Carlos Simón +11 more
TL;DR: Preimplantation genetic diagnosis for aneuploidy screening is superior compared with controls not only in clinical outcome at the first ET but also in dramatically decreasing miscarriage rates and shortening the time to pregnancy.
Journal ArticleDOI
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
Juan A. Garcia-Velasco,L. Moreno,Alberto Pacheco,A. Guillen,Luis Duque,Antonio Requena,Antonio Pellicer +6 more
TL;DR: Adding 2.5 mg of letrozole to a high-dose FSH/hMG antagonist protocol increases intraovarian androstenedione and T concentration and improves IVF cycle outcome in poor responder patients.
Journal ArticleDOI
Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates.
TL;DR: It is concluded that scheduling FET with HRT on weekdays and avoiding work overload at weekends prove efficient and safe in cycle outcome terms.
Journal ArticleDOI
The impact of in-vitro maturation of oocytes on aneuploidy rate.
TL;DR: Although a greater incidence of miscarriage or congenital abnormalities in babies born alive following IVM versus conventional IVF has not been observed in previous studies, preimplantation genetic aneuploidy screening or prenatal chromosome studies may be recommended to patients on the basis of the present results.